The discovery may help cut down unwanted side effects, such as hair loss, tiredness and nausea from chemotherapy in cancer patients.
It could also make treatment more targeted than existing therapies, researchers said.
The side effects occur when chemotherapy drugs carried in the blood kill healthy cells as well as cancer cells.
The scientists found that they could alter the chemical composition of commonly used chemotherapy drugs so that they only become active when they come into contact with a metal called palladium.
The approach led by scientists from the University of Edinburgh, UK will first need to be tested in animals before it can be studied in patients, researchers said.
"It will be several years before we're able to start treating patients but we're hopeful that this approach will lead to better tolerated cancer therapies in the future," Dr Asier Unciti-Broceta, who led the study, said.
The discovery was published in the journal Nature Communications.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
